Discovery of antigen and toxin profiles in Clostridioides difficile disease
Recruiting
- Conditions
- A04.7Enterocolitis due to Clostridium difficile
- Registration Number
- DRKS00033279
- Lead Sponsor
- Abteilung für Infektions- und Tropenmedizin, LMU Klinikum München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
signed written consent before undertaking any study specific activity
available for the first two sample time points ( in the C.diff. group); 3rd timepoint is optional
aged between 18-99 years
Exclusion Criteria
unable to provide consent
underlying psychological disease
Hepatitis A diagnosis
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of antigens and toxins before and after treatment against C.diff and comparison with healthy/diseased control groups to identify any cross-reactivity.
- Secondary Outcome Measures
Name Time Method RNA and DNA signatures of pathogens in stool of C.diff. and control groups